127 related articles for article (PubMed ID: 29374382)
21. Influence of exogenous insulin on C-peptide levels in subjects with type 2 diabetes.
Albareda M; Rigla M; Rodríguez-Espinosa J; Caballero A; Chico A; Cabezas R; Carreras G; Pérez A
Diabetes Res Clin Pract; 2005 Jun; 68(3):202-6. PubMed ID: 15936461
[TBL] [Abstract][Full Text] [Related]
22. Acute effects of the glucagon-like peptide-1 receptor agonist, exenatide, on blood pressure and heart rate responses to intraduodenal glucose infusion in type 2 diabetes.
Thazhath SS; Marathe CS; Wu T; Chang J; Khoo J; Kuo P; Checklin HL; Bound MJ; Rigda RS; Horowitz M; Jones KL; Rayner CK
Diab Vasc Dis Res; 2017 Jan; 14(1):59-63. PubMed ID: 27941058
[TBL] [Abstract][Full Text] [Related]
23. Palaeolithic diet decreases fasting plasma leptin concentrations more than a diabetes diet in patients with type 2 diabetes: a randomised cross-over trial.
Fontes-Villalba M; Lindeberg S; Granfeldt Y; Knop FK; Memon AA; Carrera-Bastos P; Picazo Ó; Chanrai M; Sunquist J; Sundquist K; Jönsson T
Cardiovasc Diabetol; 2016 May; 15():80. PubMed ID: 27216013
[TBL] [Abstract][Full Text] [Related]
24. Suppression of glucagon secretion is lower after oral glucose administration than during intravenous glucose administration in human subjects.
Meier JJ; Deacon CF; Schmidt WE; Holst JJ; Nauck MA
Diabetologia; 2007 Apr; 50(4):806-13. PubMed ID: 17334652
[TBL] [Abstract][Full Text] [Related]
25. Sugar-free zinc gluconate glycine lozenges (Cold-Eeze) do not adversely affect glucose control in patients with type 1 or type 2 diabetes mellitus.
Schwartz SL; Fischer JS; Kipnes MS
Am J Ther; 2001; 8(4):247-52. PubMed ID: 11441324
[TBL] [Abstract][Full Text] [Related]
26. Zinc supplementation for the prevention of type 2 diabetes mellitus.
Beletate V; El Dib RP; Atallah AN
Cochrane Database Syst Rev; 2007 Jan; (1):CD005525. PubMed ID: 17253560
[TBL] [Abstract][Full Text] [Related]
27. Eight weeks of treatment with long-acting GLP-1 analog taspoglutide improves postprandial insulin secretion and sensitivity in metformin-treated patients with type 2 diabetes.
Gastaldelli A; Nauck MA; Balena R
Metabolism; 2013 Sep; 62(9):1330-9. PubMed ID: 23831441
[TBL] [Abstract][Full Text] [Related]
28. Association between zinc nutritional status and glycemic control in individuals with well-controlled type-2 diabetes.
Perez A; Rojas P; Carrasco F; Basfi-Fer K; Perez-Bravo F; Codoceo J; Inostroza J; Galgani JE; Gilmore LA; Ruz M
J Trace Elem Med Biol; 2018 Dec; 50():560-565. PubMed ID: 29631853
[TBL] [Abstract][Full Text] [Related]
29. Comparison of a carbohydrate-free diet vs. fasting on plasma glucose, insulin and glucagon in type 2 diabetes.
Nuttall FQ; Almokayyad RM; Gannon MC
Metabolism; 2015 Feb; 64(2):253-62. PubMed ID: 25458830
[TBL] [Abstract][Full Text] [Related]
30. Hyperglycemia and obesity as determinants of glucose, insulin, and glucagon responses to beta-endorphin in human diabetes mellitus.
Giugliano D; Salvatore T; Cozzolino D; Ceriello A; Torella R; D'Onofrio F
J Clin Endocrinol Metab; 1987 Jun; 64(6):1122-8. PubMed ID: 2952663
[TBL] [Abstract][Full Text] [Related]
31. Effects of bovine prostate powder on zinc, glucose, and insulin metabolism in old patients with non-insulin-dependent diabetes mellitus.
Song MK; Rosenthal MJ; Naliboff BD; Phanumas L; Kang KW
Metabolism; 1998 Jan; 47(1):39-43. PubMed ID: 9440475
[TBL] [Abstract][Full Text] [Related]
32. Effects of insulin on fasting and meal-stimulated somatostatin-like immunoreactivity in noninsulin-dependent diabetes mellitus: evidence for more than one mechanism of action.
Gutniak M; Grill V; Efendić S
J Clin Endocrinol Metab; 1986 Jan; 62(1):77-83. PubMed ID: 2866196
[TBL] [Abstract][Full Text] [Related]
33. Glucose-dependent insulinotropic polypeptide: blood glucose stabilizing effects in patients with type 2 diabetes.
Christensen MB; Calanna S; Holst JJ; Vilsbøll T; Knop FK
J Clin Endocrinol Metab; 2014 Mar; 99(3):E418-26. PubMed ID: 24423311
[TBL] [Abstract][Full Text] [Related]
34. Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus.
Gutniak M; Orskov C; Holst JJ; Ahrén B; Efendic S
N Engl J Med; 1992 May; 326(20):1316-22. PubMed ID: 1348845
[TBL] [Abstract][Full Text] [Related]
35. Effects of subcutaneous, low-dose glucagon on insulin-induced mild hypoglycaemia in patients with insulin pump treated type 1 diabetes.
Ranjan A; Schmidt S; Madsbad S; Holst JJ; Nørgaard K
Diabetes Obes Metab; 2016 Apr; 18(4):410-8. PubMed ID: 26743775
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms for the antihyperglycemic effect of sitagliptin in patients with type 2 diabetes.
Muscelli E; Casolaro A; Gastaldelli A; Mari A; Seghieri G; Astiarraga B; Chen Y; Alba M; Holst J; Ferrannini E
J Clin Endocrinol Metab; 2012 Aug; 97(8):2818-26. PubMed ID: 22685234
[TBL] [Abstract][Full Text] [Related]
37. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
[TBL] [Abstract][Full Text] [Related]
38. Effect of exogenously administered glucagon versus spontaneous endogenous counter-regulation on glycaemic recovery from insulin-induced hypoglycaemia in patients with type 2 diabetes treated with a novel glucokinase activator, AZD1656, and metformin.
Krentz AJ; Morrow L; Petersson M; Norjavaara E; Hompesch M
Diabetes Obes Metab; 2014 Nov; 16(11):1096-101. PubMed ID: 24909093
[TBL] [Abstract][Full Text] [Related]
39. Blood glucose control in healthy subject and patients receiving intravenous glucose infusion or total parenteral nutrition using glucagon-like peptide 1.
Nauck MA; Walberg J; Vethacke A; El-Ouaghlidi A; Senkal M; Holst JJ; Gallwitz B; Schmidt WE; Schmiegel W
Regul Pept; 2004 Apr; 118(1-2):89-97. PubMed ID: 14759561
[TBL] [Abstract][Full Text] [Related]
40. Insulin infusion suppresses while glucose infusion induces Toll-like receptors and high-mobility group-B1 protein expression in mononuclear cells of type 1 diabetes patients.
Dandona P; Ghanim H; Green K; Sia CL; Abuaysheh S; Kuhadiya N; Batra M; Dhindsa S; Chaudhuri A
Am J Physiol Endocrinol Metab; 2013 Apr; 304(8):E810-8. PubMed ID: 23403945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
